Daphne Zohar

About Daphne Zohar

Daphne Zohar is a chief executive officer and director at Seaport Therapeutics.

Daphne Zohar reports to the SEC as a director or officer of 2 public companies, including Adicet Bio (ACET).

Daphne Zohar first appears on SEC filings in 2018.

Experience

This experience comes from SEC filings. The years are when the filings name Daphne Zohar in the role, so the role may have started earlier or lasted longer.

Key Colleagues at Startups

The people Daphne Zohar works with at each company, as listed on that company's latest Form D.

Sources

1. SECSeaport Therapeutics, Inc. Form D, filed Oct 31, 2024
2. SECForms 3, 4 and 5 filed by Daphne Zohar (SEC filer 1727388)